Author:
Zhang Yan,Ding Likun,Tian Yun,Yang Jing,Yang Lin,Wen Aidong
Subject
Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Biology,General Medicine,Biochemistry,Analytical Chemistry
Reference6 articles.
1. DHHS/FDA/CDER. Guidance for Industry, Bioanalytical Method Validation. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, May 2001.
2. Simple, sensitive, and rapid LC-ESI-MS method for quantification of mitiglinide in human urine;Liang;Chromatographia,2007
3. Pharmacological and clinical profile of mitiglinide calcium hydrate (Glufast), a new insulinotropic agent with rapid onset;Ojima;Nippon Yakurigaku Zasshi,2004
4. Effect of mitiglinide (S 21403) on Kir6.2/SUR1, Kir6.2/SUR2A and on Kir6.2/SUR2B types of ATP-sensitive potassium channel;Reimann;British Journal of Pharmacology,2001
5. The effects of mitiglinide KAD-1229, a new antidiabetic drug, on ATP-sensitive K+ channels and insulin secretion: comparison with the sulfonylureas and nateglinide;Sunaga;European Journal of Pharmacology,2001
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献